Expression of AgNOR in Benign, Borderline and Malignant Epithelial Tumors of Ovary and its Correlation with Serum CA 125

Authors

  • Maksuda Pervin Assistant Professor, Department of Pathology, Enam Medical College, Savar, Dhaka
  • Mashrufa Rahman Assistant Professor, Department of Pathology, Monno Medical College, Manikganj
  • Sharmeen Jahan Assistant Professor, Department of Pathology, Shaheed M. Monsur Ali Medical College, Sirajganj
  • Mamun Ali Biswas Professor, Department of Pathology, Enam Medical College, Savar, Dhaka
  • Afroz Shirin Associate Professor, Department of Pathology, Enam Medical College, Savar, Dhaka

DOI:

https://doi.org/10.3329/jemc.v12i3.78178

Keywords:

Benign, Borderline, mAgNOR, Malignant, Ovarian tumor, pAgNOR, Serum CA 125

Abstract

Background: CA 125, as a biomarker, holds promise in a wide range of applications, including risk assessment, early detection, diagnosis, prognosis, monitoring, and therapy. Objectives: To find out expression of AgNOR staining in benign, borderline and malignant epithelial tumors of ovary and its correlation with serum CA 125. Materials and Methods: The cross-sectional analytical study, spanning from March 2018 to July 2020 in the Department of Pathology, Sir Salimullah Medical College, Dhaka included 70 diagnosed cases of ovarian epithelial tumors with known CA 125 status. Paraffin blocks and CA 125 reports were gathered, ensuring ethical practices throughout. Results: The mean CA 125 levels in patients with benign was 61.70±30.75 U/mL, in borderline group 65.0±7.07 U/mL and in malignant cases 463.67±249.48 U/mL. CA 125 level was significantly higher in malignant tumors compared to benign and borderline (p<0.001). There was significant positive correlation between CA 125 with mAgNOR (r=0.821; p=0.001) and with pAgNOR (r=0.853; p=0.001). Conclusion: Elevated CA 125 levels were notably significant in malignant tumors compared to benign and borderline cases. A strong, positive correlation existed between CA 125 and both mAgNOR and pAgNOR.

J Enam Med Col 2022; 12(3): 137−142

Downloads

Abstract
27
PDF
19

Downloads

Published

2025-04-08

How to Cite

Pervin, M., Rahman, M., Jahan, S., Biswas, M. A., & Shirin, A. (2025). Expression of AgNOR in Benign, Borderline and Malignant Epithelial Tumors of Ovary and its Correlation with Serum CA 125. Journal of Enam Medical College, 12(3), 137−142. https://doi.org/10.3329/jemc.v12i3.78178

Issue

Vol. 12 No. 3 (2022)

Section

Original Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

  • Copyright on any research article is transferred in full to Journal of Enam Medical College upon publication in the journal. The copyright transfer includes the right to reproduce and distribute the article in any form of reproduction (printing, electronic media or any other form).
  • Articles in the Journal of Enam Medical College are Open Access articles published under the Creative Commons CC BY License (https://creativecommons.org/licenses/by/4.0/)
  • This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.